Thought Leadership
At SSI Strategy, we believe that knowledge is a key driver in building better biotechs. Our Insights provide valuable information and expert perspectives to empower biotech leaders like you.
Articles and White Papers
All services
Development Strategy
Medical Devices
Pharmacovigilance
NDA Advisory Board
Strategic Communications
Regulatory
Quality & Compliance
All expertise
Oncology
Vaccine
Immunogenicity
HTA
In-Vitro Diagnostics
Non-Clinical
Cell and Gene Therapy
Biostatistics
Cardiology
ATMP
Rare Disease
Market Access
CMC
Clinical
Paediatric
Acceleration Strategies
Medical Devices
Quality
Patient Safety
22-11-2024
AI Meets the Office: Lessons from Our Microsoft Copilot Pilot
As technological advancement is reshaping the business landscape at an unprecedented pace, the integration of Artificial Intelligence (AI) has become a necessity for organizations aiming to maintain their competitive edge.
22-11-2024
Unmet Medical Need: A Regulatory Perspective
Without clarity on how unmet medical need is evaluated, even a promising product can face delays or missteps. Clarity and alignment are the keys to success.
16-10-2024
EU HTA Regulation Insights: Expert Strategies for Success
Get insights into the new EU Health Technology Assessment (HTA) Regulation and its significant implications for the biotech and drug development sectors.
30-07-2024
Driving Therapeutic Impact: A Novel Model for Strategic Medical Affairs Integration
Implement a cross-functional team structure that includes Medical Affairs from the outset and develop a comprehensive evidence generation plan that goes beyond regulatory requirements.
30-07-2024
EU HTA Regulation: What’s changing & why it matters!
Get insights into the new EU Health Technology Assessment (HTA) Regulation and its significant implications for the biotech and drug development sectors.
12-01-2024
Joint Scientific Consultations – Advice for EU Health Technology Assessment
Get expert advice on your drug or device development through the EU's Joint Scientific Consultation. This voluntary program lets developers receive feedback from EU health technology assessment bodies on their clinical study designs and evidence needs.
LET'S TALK
You don't have to go it alone!
Our experienced team has been there before, and we're ready to guide you through the unknown.Share your challenges with us, and together, we'll create a plan to efficiently reach your milestones and turn your vision into reality.
Building Better Biotechs
